Celebrating 40 years. Eyecare Business reached out to our board members and past #EBGameChangers for their thoughts on how eyewear and eye care have changed since our launch in 1986.
The approval establishes the first and only FDA-approved ophthalmic formulation of bevacizumab for neovascular age-related macular degeneration in the US.
Drawing on his experience caring for veterans in northern California, Frank Brodie, MD, MBA, explains why gene therapy may be particularly meaningful for patients who travel long distances for routine anti-VEGF treatment.